The ride-hailing leader is proving that its capital-light strategy for the self-driving transition has significant potential.
New data supports GraftAssure commercialization effortsMulti-center study featured 249 biopsy-matched patientsProprietary ...
Pomdoctor Limited ('Pomdoctor' or the 'Company') (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced a strategic upgrade centered on the core track ...